David Migl
InvestorAssociate at RA Capital
Boston, Massachusetts
Writes $100K – $5M checks · typically $1.5M
About
David Migl is a therapeutics investor with six years of experience at RA Capital, where he analyzed preclinical through Phase 3 assets in mid-to-late stage private companies and public equities. His coverage spans oncology, immunology, rare disease, respiratory, and internal medicine. He holds a PhD in Biophysics from Harvard.
Experience
- RA Capital Management, L.P.Analyst2023 — 2025
- RA Capital Management, L.P.Associate2019 — 2022Boston, MA
Education
- Harvard UniversityDoctor of Philosophy - PhD, Biophysics
- Texas A&M UniversityBachelor’s Degree, Molecular Biology
Skills & more
StrategyCompetitive IntelligenceFinancial ModelingBusiness DevelopmentCompetitive LandscapeDue DiligenceMarket Research
From David's professional profile.
Colleagues at RA Capital
Network5
Alyssa Larson
Investor at RA Capital
Andrew Levin
Partner at RA Capital
Anthony Arceci
Senior Associate at RA Capital
Anurag Kondapalli
Principal at RA Capital
Daniel Bahcheli
Investor at RA Capital
Investors connected to David in public investor directories — a warm-intro map.
Frequently asked questions
- Where does David Migl work?
- David Migl is Associate at RA Capital.
- What check size does David Migl write?
- David Migl typically writes checks of $100K – $5M.
Same school
Also attended Harvard University1,455
Alfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalGRyan IsonoDeal Partner at Felicis Ventures
+ 1,449 more
Also attended Texas A&M University131
Kanu GulatiInvestor at Khosla VenturesNathaniel HardingManaging Partner at Cortado VenturesJackie PfisterChief Operating Officer at Mercury FundLisa RobertsChief Product Officer at Mercury FundBrent KeltonPartner & Texas Leader at Moneta VenturesLori DeLucaChief Financial Officer at Chingona Ventures
+ 125 more
